Four-year clinical results of transcatheter self-expanding Medtronic CoreValve implantation in high-risk patients with severe aortic stenosis | Zendy

Sofia Thomopoulou | Zendy; Manolis Vavuranakis | Zendy; Panagiotis Karyofyllis | Zendy; Maria Kariori | Zendy; George Karavolias | Zendy; Marina Balanika | Zendy; Anna Smyrli | Zendy; Christos Stefopoulos | Zendy; Eftihia Sbarouni | Zendy; Carmen Moldovan | Zendy; Mazen Khoury | Zendy; Christodoulos Stefanadis | Zendy; Vassilis Voudris | Zendy

Open Access

Four-year clinical results of transcatheter self-expanding Medtronic CoreValve implantation in high-risk patients with severe aortic stenosis

Author(s) -

Sofia Thomopoulou,

Manolis Vavuranakis,

Panagiotis Karyofyllis,

Maria Kariori,

George Karavolias,

Marina Balanika,

Anna Smyrli,

Christos Stefopoulos,

Eftihia Sbarouni,

Carmen Moldovan,

Mazen Khoury,

Christodoulos Stefanadis,

Vassilis Voudris

Publication year - 2016

Publication title -

age and ageing

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.014

H-Index - 143

eISSN - 1468-2834

pISSN - 0002-0729

DOI - 10.1093/ageing/afw038

Subject(s) - medicine , stenosis , cardiology , ejection fraction , cumulative incidence , regurgitation (circulation) , aortic valve replacement , aortic valve stenosis , surgery , prosthesis , stroke (engine) , incidence (geometry) , euroscore , heart failure , cohort , artery , physics , optics , mechanical engineering , engineering

ranscatheter aortic valve implantation (TAVI) has emerged as an alternative to surgical aortic valve replacement for patients with severe aortic stenosis considered inoperable or at high operative risk, but the long-term outcome remains unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research